| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 01/20/2011 | WO2010007441A3 Phosphopeptides and use of the same |
| 01/20/2011 | US20110015663 Combination Therapies for the Treatment of Obesity |
| 01/20/2011 | US20110015437 Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands |
| 01/20/2011 | US20110015263 Therapeutic delivery of carbon monoxide |
| 01/20/2011 | US20110015257 Hypoxia Inducible VEGF Plasmid for Ischemic Disease |
| 01/20/2011 | US20110015252 Lipid formulated dsrna targeting the pcsk9 gene |
| 01/20/2011 | US20110015247 Novel crystalline form of carvedilol dihydrogen phosphate and related processes |
| 01/20/2011 | US20110015240 Thiazole derivative and use thereof as vap-1 inhibitor |
| 01/20/2011 | US20110015238 Blood flow promoters for cauda equina tissues |
| 01/20/2011 | US20110015230 Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same |
| 01/20/2011 | US20110015226 Treatment of Energy Utilization Disease |
| 01/20/2011 | US20110015224 Combination of a carbostyril and carnitine |
| 01/20/2011 | US20110015213 Quinazoline derivatives |
| 01/20/2011 | US20110015212 Pyrimidinones as pi3k inhibitors |
| 01/20/2011 | US20110015210 Pyrazinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes |
| 01/20/2011 | US20110015206 Method of stabilizing lipid-rich plaque and method of preventing rupture thereof |
| 01/20/2011 | US20110015195 Aryl ureas with angiogenisis inhibiting activity |
| 01/20/2011 | US20110015184 Vinyl-phenyl derivatives for inflammation and immune-related uses |
| 01/20/2011 | US20110015183 Substituted pyrazole sigma receptor antagonists |
| 01/20/2011 | US20110015178 Amido-Thiophene Compounds and Their Use |
| 01/20/2011 | US20110015167 Use of norgestimate as a selective inhibitor of trpc3, trpc6 and trpc7 ion channels |
| 01/20/2011 | US20110015166 Topically Active Steroids for Use in Interstitial Pulmonary Fibrosis |
| 01/20/2011 | US20110015165 Modified, hydroxy-substituted aromatic structures having cytoprotective activity |
| 01/20/2011 | US20110015159 Methods of inhibiting vascular permeability and apoptosis |
| 01/20/2011 | US20110015157 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| 01/20/2011 | US20110015140 Anti-diabetes composition containing chicoric acid and/or one of the metabolites thereof |
| 01/20/2011 | US20110015129 New paediatric indications for direct thrombin inhibitors |
| 01/20/2011 | US20110015127 Targeting complement factor h for treatment of diseases |
| 01/20/2011 | US20110015123 Modulation of GLUT4 Gene Promoter activity BY AHNAK |
| 01/20/2011 | US20110014307 Blood vessel maturation, normalization or stabilization agent and wrinkle preventer/improver |
| 01/20/2011 | US20110014294 Stimulation of ocular retrobulbar blood flow using ocular irritants |
| 01/20/2011 | US20110014291 Novel Polymorphs of Bosentan |
| 01/20/2011 | US20110014282 Pharmaceutical composition for poorly soluble drugs |
| 01/20/2011 | US20110014279 Bioactive complex compositions and methods of use thereof |
| 01/20/2011 | US20110014270 Prevention and treatment of ischemia-reperfusion injury and related conditions |
| 01/20/2011 | US20110014251 Microvesicles |
| 01/20/2011 | US20110014203 Formulation |
| 01/20/2011 | US20110014201 Il-18 receptor antigen binding proteins |
| 01/20/2011 | US20110014198 Anti-vegf antibodies |
| 01/20/2011 | US20110014189 Stable pharmaceutical composition comprising at least one monoclonal antibody and at least one amphiphilic polysaccharide comprising hydrophobic substituents |
| 01/20/2011 | US20110014186 Arylsulfonamide-based matrix metalloprotease inhibitors |
| 01/20/2011 | US20110014176 Compounds and method for reducing uric acid |
| 01/20/2011 | US20110014174 Lysozyme, A Novel Vasodilator of Sepsis that can be inhibited by a Peroxidase and Hydroxyl Radical Scavengers |
| 01/20/2011 | US20110014164 Efficient induction of pluripotent stem cells using small molecule compounds |
| 01/20/2011 | US20110014159 Method for obtaining characterized muscle-derived cell populations and uses |
| 01/20/2011 | US20110014128 Cytokine receptor modulators, method of identifying same, and method of modulating cytokine receptors activity with same |
| 01/20/2011 | US20110014124 Targeted atherosclerosis treatment |
| 01/20/2011 | DE102009033396A1 Wässrige Lösung und gelatinierte Zusammensetzung umfassend einen Phosphodiesterase-5-Inhibitor sowie diesbezügliche Verfahren und Verwendung Aqueous solution and gelatinized composition comprising a phosphodiesterase-5 inhibitor, and related procedures and use |
| 01/20/2011 | CA2768104A1 Combination of a sodium-proton exchanger inhibitor and of a dihydro-1,3,5-triazine amine derivative |
| 01/20/2011 | CA2767894A1 Apoptosis signal-regulating kinase inhibitors |
| 01/19/2011 | EP2275557A1 Albumin fusion proteins |
| 01/19/2011 | EP2275437A1 Polypeptide and pharmaceutical composition containing the polypeptide |
| 01/19/2011 | EP2275416A1 Biologically active methylene blue derivatives |
| 01/19/2011 | EP2275404A1 Homocysteine synthase inhibitor |
| 01/19/2011 | EP2275140A2 Composition comprising plant and/or fish oils and non-oxidizable fatty acid entities |
| 01/19/2011 | EP2275117A1 GLP-1, exendin-4, peptide analogs and uses thereof |
| 01/19/2011 | EP2275106A1 Combination drug containing probucol and a tetrazolylalkoxy-dihydrocarbostyril derivative with superoxide supressant effects |
| 01/19/2011 | EP2275102A1 N3 alkylated benzimidazole derivatives as MEK inhibitors |
| 01/19/2011 | EP2275099A1 Treatment of faecal incontinence with 1r,2s-methoxamine |
| 01/19/2011 | EP2275093A2 Pharmaceutical formulation |
| 01/19/2011 | EP2275091A1 Pharmaceutical compositions comprising adsorbates of an amorphous drug |
| 01/19/2011 | EP2274308A1 Pyrrolotriazinone derivatives for use as stearoyl coa desaturase inhibitors |
| 01/19/2011 | EP2274299A1 Heteroaryl-substituted dicyanopyridines and use thereof for treatment of cardiovascular diseases |
| 01/19/2011 | EP2274295A1 3, 4 - substituted piperidine derivatives as renin inhibitors |
| 01/19/2011 | EP2274053A2 Use of the human pancreatic polypeptide as a therapeutic agent |
| 01/19/2011 | EP2274002A2 Leucine-rich peptide compositions and methods for isolation |
| 01/19/2011 | EP2273996A2 Human cardiovascular progenitor cells |
| 01/19/2011 | EP2273985A2 Capsule for the prevention of cardiovascular diseases |
| 01/19/2011 | EP1773867B1 Proteinaceous compounds and uses therefor |
| 01/19/2011 | EP1693456B1 Method of identifying modulators of a g protein-coupled receptor |
| 01/19/2011 | EP1608623B1 Metal ion chelators and therapeutic use thereof |
| 01/19/2011 | EP1481969B1 Piperidine derivative compounds and drugs containing the compounds as the active ingredient |
| 01/19/2011 | EP1432416B1 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
| 01/19/2011 | EP1409008B1 Use of a nucleic acid molecule coding the disintegrin domain of an adamalysin as anti-angiogenic, anti-invasive and anti-metastatic agent |
| 01/19/2011 | EP1330442B1 Phthalazinone derivatives |
| 01/19/2011 | EP1325019B1 Antisense modulation of clusterin expression |
| 01/19/2011 | EP1252300B1 Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon |
| 01/19/2011 | CN201710672U Apoplexy plaster |
| 01/19/2011 | CN201709412U Health and massage bra pad containing cassia seeds |
| 01/19/2011 | CN1989117B Substituted benzothiazoles |
| 01/19/2011 | CN1950389B Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs |
| 01/19/2011 | CN1929847B Fasudil-containing preparation and method of improving stability thereof |
| 01/19/2011 | CN1814170B Medicinal drop pills for treating cardiovascular disease and preparing method |
| 01/19/2011 | CN1355171B Extracting process and usage of general aralic chinensis saponin |
| 01/19/2011 | CN101952280A Bicyclic heterocyclic derivative |
| 01/19/2011 | CN101952276A 5-halogen-substituted oxindole derivatives and use thereof for treating vasopressine-dependent diseases |
| 01/19/2011 | CN101952259A Benzodiazepine compound and pharmaceutical composition |
| 01/19/2011 | CN101952249A Process and intermediates for the preparation of 5-biphenyl-4-yl-2-methylpentanoic acid derivatives |
| 01/19/2011 | CN101952243A 4-dimethylaminobutyric acid derivatives |
| 01/19/2011 | CN101951991A New medical use of 3-(2,2,2-trimethylhydrazinium) propionate salts |
| 01/19/2011 | CN101951953A Pharmaceutical composition comprising anti-GRP78 antibody as active ingredient |
| 01/19/2011 | CN101951935A Therapeutic agent for cerebral ischemic injury |
| 01/19/2011 | CN101951917A Treating hypertension with 25-hydroxyvitamin D3 |
| 01/19/2011 | CN101951915A Oxsterols for activation of hedgehog signaling, osteoinduction, antiadipogenesis, and WNT signaling |
| 01/19/2011 | CN101951898A Medical use of 3-(2,2,2-trimethylhydrazinium) propionate hydrogen fumarate and dihydrogen phosphate |
| 01/19/2011 | CN101951897A Use of amidoxime carboxylic acid esters and N-hydroxyguanidine carboxylic acid esters for producing prodrugs |
| 01/19/2011 | CN101948539A IL-18 binding proteins |
| 01/19/2011 | CN101948499A Pseudoginsenoside G1 and extraction method and medicinal applications thereof |
| 01/19/2011 | CN101948498A Pseudo-ginsenoside G2, extraction method and drug application thereof |
| 01/19/2011 | CN101948497A Ginsenoside R10, extraction method and pharmaceutical use thereof |